Holen Sie sich die Stockscreener-App
9.23
0.97%
-0.09
Handel nachbörslich:
9.33
0.10
+1.08%
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Analysts Apply Wyckoff Model to Emergent BioSolutions Inc. Stock2025 Market WrapUp & Fast Moving Market Watchlists - beatles.ru
Technical Bounce Expected in Emergent BioSolutions Inc. Next WeekJuly 2025 Analyst Calls & Risk Managed Trade Strategies - thegnnews.com
Emergent BioSolutions : From Cost Center to Value Driver - MarketScreener
Three Analyst Favorites with Potential for Further Gains: SkyWater Technology, Emergent BioSolutions, and More - AInvest
Is Emergent BioSolutions Inc. stock forming a cup and handleTrade Volume Summary & High Conviction Buy Zone Picks - thegnnews.com
Emergent BioSolutions Board Member Sells $67K in Company Stock Amid Revenue Decline. - AInvest
Emergent BioSolutions signs contract modification award for CNJ-016 - MSN
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO’s Insider Sales - ACCESS Newswire
Emergent BioSolutions' (NYSE:EBS) Solid Earnings May Rest On Weak Foundations - simplywall.st
Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 27% - 富途牛牛
We Think That There Are Some Issues For Emergent BioSolutions (NYSE:EBS) Beyond Its Promising Earnings - Yahoo Finance
Emergent BioSolutions Inc. Outperforms Peers on Volume MetricsQuarterly Risk Review & Smart Allocation Stock Reports - newsyoung.net
RSI Suggests Rebound May Be Near in Emergent BioSolutions Inc.2025 Volume Leaders & Daily Stock Momentum Reports - beatles.ru
Emergent BioSolutions Director Sells 7,844 Shares at $8.65/Share on August 12, 2025. - AInvest
Emergent BioSolutions’ Earnings Call Highlights Strong Financial Performance - The Globe and Mail
Emergent BioSolutions’ Strong Q2 Fuels Hopes for 2025 Rally - citybiz
300 new jobs headed to Bayview manufacturing plant - The Business Journals
Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally - Seeking Alpha
Emergent Biosolutions: Strategic Advancements and Financial Performance Drive Buy Rating - TipRanks
Emergent BioSolutions Reports Improved Q2 2025 Results - TipRanks
Published on: 2025-08-10 18:27:00 - metal.it
Earnings Update: Here's Why Analysts Just Lifted Their Emergent BioSolutions Inc. (NYSE:EBS) Price Target To US$13.50 - simplywall.st
Emergent BioSolutions Inc. (NYSE:EBS) Q2 2025 Earnings Call Transcript - Insider Monkey
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - MSN
Emergent BioSolutions' Strong ROE Amid Industry Average: A Financial Analysis - AInvest
Can Emergent BioSolutions Inc. (NYSE:EBS) Maintain Its Strong Returns? - Yahoo Finance
Emergent BioSolutions to participate in investor conferences in May and June 2025. - AInvest
Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Emergent BioSolutions Updates FY25 Revenue Guidance to $765M-$835M - AInvest
BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd - Law360
Emergent BioSolutions Surpasses Q2 Revenue Expectations - The Globe and Mail
Emergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year - TipRanks
Emergent BioSolutions Soars 22% on Earnings Surprise: What's Fueling the Surge? - AInvest
Emergent Biosolutions reports second quarter loss - Maryland Daily Record
Emergent Biosolutions shares rise 6.14% premarket after securing $51.9 million contract modification for smallpox preparedness. - AInvest
Installed Building Products reports record Q2 2025 results, 3.1% revenue increase. - AInvest
Emergent Biosolutions Q2 Earnings Report: $12 Million LossNews and Statistics - IndexBox
Emergent Biosolutions: Q2 Earnings Snapshot - Huron Daily Tribune
Emergent BioSolutions Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Emergent BioSolutions Q2 2025 results show mixed performance - Investing.com
Emergent BioSolutions Outpaces Its Own Forecasts But Misses Analyst Targets - Finimize
Emergent Biosolutions earnings beat by $0.26, revenue fell short of estimates - Investing.com Canada
Emergent BioSolutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Emergent BioSolutions Q2 revenue misses analyst expectations - MarketScreener
Emergent BioSolutions Inc Q2 2025 Earnings: EPS of -$0.22 Beats Estimates, Revenue Surges to $140.9 Million - GuruFocus
Emergent BioSolutions Q2 2025 slides: Profitability improves as transformation continues - Investing.com Canada
Emergent Biosolutions Q2 Earnings: Non-GAAP EPS Beats by $0.65, Revenue Misses by $5.47M - AInvest
Emergent BioSolutions Reports Second Quarter 2025 Financial Results - The Manila Times
Emergent BioSolutions Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
What drives Emergent BioSolutions Inc. stock priceInvest confidently with real-time data analysis - Jammu Links News
Is it the right time to buy Emergent BioSolutions Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How many analysts rate Emergent BioSolutions Inc. as a “Buy”Strong return on assets - Jammu Links News
What catalysts could drive Emergent BioSolutions Inc. stock higher in 2025Access high-yield investment alerts now - Jammu Links News
Is Emergent BioSolutions Inc. stock overvalued or undervaluedTriple returns potential - Jammu Links News
2.37%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):